MEGAN MORITZ: Open Payments
NPI 1194114884 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 16 payments from 6 companies in 2025. Trend: 2023 $474 · 2024 $657 · 2025 $350
Food & beverage: $316Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $172 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Amgen Inc. | 1 | $34 |
| Integra LifeSciences Corporation | 1 | $19 |
| Optinose US, Inc. | 1 | $17 |
Products named: DUPIXENT, NUCALA, ACCLARENT AERA, Xhance.
Industry payments across OK — which companies pay providers there.
